YourChoice Therapeutics is developing a non-hormonal contraceptive pill for men that blocks sperm release and cell division, achieving a contraceptive efficacy of 99% in preclinical trials. This product addresses the lack of effective male contraceptive options, providing a reversible solution with a return to normal fertility levels after discontinuation.
Funding
$17.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
OTSBFounders
Product
Problem
Current male contraceptive options are limited to condoms or vasectomy, with a lack of easily reversible and highly effective methods. Existing methods also place a disproportionate burden on women for family planning.
Solution
YourChoice Therapeutics is developing a daily, non-hormonal contraceptive pill for men designed to be highly effective and easily reversible. The drug candidate impacts a known target, blocking both sperm release and cell division through a proprietary mechanism. Preclinical trials have demonstrated 99% efficacy in preventing pregnancy, with a return to normal fertility levels after discontinuing use. This approach aims to provide men with a convenient and reliable option for managing their fertility.
Target Audience
The primary target audience is men seeking a reliable, reversible, and convenient form of contraception, as well as couples looking for more balanced family planning options.
Features
- Non-hormonal mechanism of action to minimize side effects
- Targets sperm release and cell division for dual-action contraception
- Demonstrated 99% contraceptive efficacy in preclinical mouse models
- Fully reversible, with a return to regular fertility levels after cessation
- Convenient daily oral administration